FMP

FMP

Enter

VRAX - Virax Biolabs G...

photo-url-https://images.financialmodelingprep.com/symbol/VRAX.png

Virax Biolabs Group Limited

VRAX

NASDAQ

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, individual consumers, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.

2.08 USD

-0.33 (-15.87%)

About

ceo

Mr. James Foster

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert emplo...

CIK

0001885827

ISIN

KYG9495L1251

CUSIP

G9495L109

Address

30 Broadwick Street

Phone

44 20 7788 7414

Country

GB

Employee

17

IPO Date

Jul 21, 2022

VRAX Financial Summary

CIK

0001885827

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

G9495L109

ISIN

KYG9495L1251

Country

GB

Price

2.08

Beta

1.93

Volume Avg.

6.12M

Market Cap

7.56M

Shares

-

52-Week

0.6-9.0

DCF

0.96

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.62

P/B

-

Website

https://viraxbiolabs.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest VRAX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep